CLINICAL_TRIALS
trial_result
· 2012-06-28
Clinical Trial Update: Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis [Phase 3]
Summary
Phase 3 clinical trial update reporting results on the safety and efficacy of golimumab in Chinese patients with ankylosing spondylitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centocor, Inc. | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2012-06-28